Literature DB >> 24166412

Alpha-2A adrenergic receptor gene variants are associated with increased intra-individual variability in response time.

T D R Cummins1, O Jacoby2, Z Hawi1, L S Nandam3, M A V Byrne2, B-N Kim4, J Wagner2, C D Chambers5, M A Bellgrove6.   

Abstract

Intra-individual variability in response time has been proposed as an important endophenotype for attention deficit hyperactivity disorder (ADHD). Here we asked whether intra-individual variability is predicted by common variation in catecholamine genes and whether it mediates the relationship between these gene variants and self-reported ADHD symptoms. A total of 402 non-clinical Australian adults of European descent completed a battery of five cognitive tasks and the Conners' Adult ADHD Rating Scale. Exclusion criteria included the presence of major psychiatric or neurologic illnesses and substance dependency. A total of 21 subjects were excluded due to incomplete data or poor quality cognitive or genotyping data. The final sample comprised 381 subjects (201 males; mean age=21.2 years, s.d.=5.1 years). Principal components analysis on variability measures yielded two factors (response selection variability vs selective attention variability). Association of these factors with catecholamine gene variants was tested using single-step linear regressions, with multiple comparisons controlled using permutation analysis. The response selection variability factor was associated with two ADRA2A single-nucleotide polymorphisms (SNPs) (rs1800544, rs602618), p corrected=0.004, 0.012, respectively, whereas the selective attention variability factor was associated with a TH SNP (rs3842727), p corrected=0.024. A bootstrapping analysis indicated that the response selection variability factor mediated the relationship between the ADRA2A SNP rs1800544 and self-reported ADHD symptoms. Thus this study finds evidence that DNA variation in the ADRA2A gene may be causally related to ADHD-like behaviors, in part through its influence on intra-individual variability. Evidence was also found for a novel association between a TH gene variant and intra-individual variability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166412     DOI: 10.1038/mp.2013.140

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  50 in total

Review 1.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes.

Authors:  F Xavier Castellanos; Rosemary Tannock
Journal:  Nat Rev Neurosci       Date:  2002-08       Impact factor: 34.870

2.  A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study.

Authors:  John S Markowitz; C Lindsay DeVane; Linda K Pestreich; Kennerly S Patrick; Rafael Muniz
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-12       Impact factor: 2.576

Review 3.  Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.

Authors:  Guilherme Polanczyk; Cristian Zeni; Julia P Genro; Tatiana Roman; Mara H Hutz; Luis Augusto Rohde
Journal:  Pharmacogenomics       Date:  2005-04       Impact factor: 2.533

Review 4.  Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Authors:  Amy F T Arnsten; Steven R Pliszka
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

5.  Response variability in attention deficit hyperactivity disorder: evidence for neuropsychological heterogeneity.

Authors:  Katherine A Johnson; Simon P Kelly; Mark A Bellgrove; Edwina Barry; Marie Cox; Michael Gill; Ian H Robertson
Journal:  Neuropsychologia       Date:  2006-12-08       Impact factor: 3.139

6.  Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD.

Authors:  Jeffery N Epstein; William B Brinkman; Tanya Froehlich; Joshua M Langberg; Megan E Narad; Tanya N Antonini; Keri Shiels; John O Simon; Mekibib Altaye
Journal:  Neuropsychopharmacology       Date:  2011-01-19       Impact factor: 7.853

7.  Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.

Authors:  Katherine A Johnson; Edwina Barry; Mark A Bellgrove; Marie Cox; Simon P Kelly; Aoife Dáibhis; Michael Daly; Michelle Keavey; Amy Watchorn; Michael Fitzgerald; Fiona McNicholas; Aiveen Kirley; Ian H Robertson; Michael Gill
Journal:  Neuropsychologia       Date:  2008-01-12       Impact factor: 3.139

8.  Staying on the job: the frontal lobes control individual performance variability.

Authors:  Donald T Stuss; Kelly J Murphy; Malcolm A Binns; Michael P Alexander
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

9.  Executive "brake failure" following deactivation of human frontal lobe.

Authors:  Christopher D Chambers; Mark A Bellgrove; Mark G Stokes; Tracy R Henderson; Hugh Garavan; Ian H Robertson; Adam P Morris; Jason B Mattingley
Journal:  J Cogn Neurosci       Date:  2006-03       Impact factor: 3.225

10.  Reaction time performance in ADHD: improvement under fast-incentive condition and familial effects.

Authors:  Penny Andreou; Ben M Neale; Wai Chen; Hanna Christiansen; Isabel Gabriels; Alexander Heise; Sheera Meidad; Ueli C Muller; Henrik Uebel; Tobias Banaschewski; Iris Manor; Robert Oades; Herbert Roeyers; Aribert Rothenberger; Pak Sham; Hans-Christoph Steinhausen; Philip Asherson; Jonna Kuntsi
Journal:  Psychol Med       Date:  2007-05-31       Impact factor: 7.723

View more
  7 in total

1.  A new locus regulating MICALL2 expression was identified for association with executive inhibition in children with attention deficit hyperactivity disorder.

Authors:  L Yang; S Chang; Q Lu; Y Zhang; Z Wu; X Sun; Q Cao; Y Qian; T Jia; B Xu; Q Duan; Y Li; K Zhang; G Schumann; D Liu; J Wang; Y Wang; L Lu
Journal:  Mol Psychiatry       Date:  2017-04-18       Impact factor: 15.992

Review 2.  The molecular genetic architecture of attention deficit hyperactivity disorder.

Authors:  Z Hawi; T D R Cummins; J Tong; B Johnson; R Lau; W Samarrai; M A Bellgrove
Journal:  Mol Psychiatry       Date:  2015-01-20       Impact factor: 15.992

3.  A Population Based Study of the Genetic Association between Catecholamine Gene Variants and Spontaneous Low-Frequency Fluctuations in Reaction Time.

Authors:  Jojanneke A Bastiaansen; Tarrant D R Cummins; Harriëtte Riese; Arie M van Roon; Ilja M Nolte; Albertine J Oldehinkel; Mark A Bellgrove
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

4.  Methylomic analysis of monozygotic twins discordant for childhood psychotic symptoms.

Authors:  Helen L Fisher; Therese M Murphy; Louise Arseneault; Avshalom Caspi; Terrie E Moffitt; Joana Viana; Eilis Hannon; Ruth Pidsley; Joe Burrage; Emma L Dempster; Chloe C Y Wong; Carmine M Pariante; Jonathan Mill
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

5.  Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.

Authors:  Annika M A Berends; Mathieu S Bolhuis; Ilja M Nolte; Edward Buitenwerf; Thera P Links; Henri J L M Timmers; Richard A Feelders; Elisabeth M W Eekhoff; Eleonora P M Corssmit; Peter H Bisschop; Harm R Haak; Ron H N van Schaik; Samira El Bouazzaoui; Bob Wilffert; Michiel N Kerstens
Journal:  Biomedicines       Date:  2022-04-13

Review 6.  Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants.

Authors:  Sergi Ferré; Annabelle M Belcher; Jordi Bonaventura; César Quiroz; Marta Sánchez-Soto; Verònica Casadó-Anguera; Ning-Sheng Cai; Estefanía Moreno; Comfort A Boateng; Thomas M Keck; Benjamín Florán; Christopher J Earley; Francisco Ciruela; Vicent Casadó; Marcelo Rubinstein; Nora D Volkow
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

7.  Genome-wide association study reveals novel genetic locus associated with intra-individual variability in response time.

Authors:  Ari Pinar; Ziarih Hawi; Tarrant Cummins; Beth Johnson; Marc Pauper; Janette Tong; Jeggan Tiego; Amy Finlay; Marieke Klein; Barbara Franke; Alex Fornito; Mark A Bellgrove
Journal:  Transl Psychiatry       Date:  2018-10-04       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.